Vanda Pharmaceuticals (VNDA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 70,022 | 80,983 | 111,796 | 102,316 | 100,497 |
| Marketable Securities | 223,730 | 244,567 | 229,112 | 272,327 | 275,764 |
| Receivables | 50,541 | 44,993 | 44,603 | 47,101 | 42,753 |
| Inventories | 2,042 | 2,169 | 1,923 | 1,726 | 1,614 |
| TOTAL | $367,496 | $394,921 | $407,910 | $438,890 | $432,387 |
| Non-Current Assets | |||||
| PPE Net | 2,460 | 2,420 | 2,439 | 2,132 | 2,178 |
| Intangibles | 108,841 | 110,593 | 112,344 | 114,096 | 115,848 |
| Other Non-Current Assets | 122,343 | 116,812 | 109,243 | 101,086 | 94,702 |
| TOTAL | $233,644 | $229,825 | $224,026 | $217,314 | $212,728 |
| Total Assets | $601,140 | $624,746 | $631,936 | $656,204 | $645,115 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 47,619 | 57,119 | 45,279 | 39,086 | 39,304 |
| Other current liabilities | 70,251 | 64,370 | 58,644 | 60,895 | 49,786 |
| TOTAL | $117,870 | $121,489 | $103,923 | $99,981 | $89,090 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 14,463 | 13,845 | 13,649 | 14,531 | 14,802 |
| TOTAL | $17,271 | $16,928 | $16,596 | $17,677 | $14,802 |
| Total Liabilities | $135,141 | $138,417 | $120,519 | $117,658 | $103,892 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 59,097 | 59,089 | 58,934 | 58,316 | 58,308 |
| Common Shares | 59 | 59 | 59 | 58 | 58 |
| Retained earnings | -253,579 | -230,993 | -203,786 | -174,292 | -169,380 |
| Other shareholders' equity | 540 | 396 | 383 | 74 | 702 |
| TOTAL | $465,999 | $486,329 | $511,417 | $538,546 | $541,223 |
| Total Liabilities And Equity | $601,140 | $624,746 | $631,936 | $656,204 | $645,115 |